KOR

e-Article

Towards understanding antimicrobial activity, cytotoxicity and the mode of action of dichapetalins A and M using in silico and in vitro studies.
Document Type
Article
Source
Toxicon. Apr2021, Vol. 193, p28-37. 10p.
Subject
*IN vitro studies
*BACILLUS cereus
*SHIGELLA flexneri
*VIRAL hepatitis
*ANTIBIOTICS
*TRYPANOSOMA
*LEISHMANIA mexicana
Language
ISSN
0041-0101
Abstract
Dichapetalum madagascariense Poir (Dichapetalaceae) is traditionally used to treat bacterial infections, jaundice, urethritis and viral hepatitis in Africa. Its root contains a broad spectrum of biologically active dichapetalins. To evaluate the plant's effect on human MCF-7 cells and its' antibacterial and antiparasitic potentials, we isolated and identified the known dichapetalins A and M from the roots. Both dichapetalins were tested on six bacterial strains (Shigella flexneri , Bacillus cereus, Salmonella paratyphi B, Listeria monocytogenes , Escherichia coli, Staphylococcus aureus) and two parasite strains; Trypanosoma brucei brucei, and Leishmania donovani using the Alamar Blue assay system. Dichapetalins A and M were more potent against B. cereus with IC 50 values of 11.15 and 3.15 μg/ml, respectively, compared to the positive control ampicillin (IC 50 = 19.50 μg/ml). Dichapetalins A (IC 50 = 74.22 μg/ml) and M (IC 50 = 72.34 μg/ml) were less active against T. b. brucei , compared to the standard Suramin (IC 50 = 4.96 μg/ml). Dichapetalin M showed moderate activity against L. donovani (Amphotericin B: IC 50 = 0.21 μg/ml) with an IC 50 of 16.80 μg/ml. In human MCF-7 cells expressing the NR1I2 receptor, the activity of dichapetalin M was higher (IC 50 = 4.71 μM and 3.95 μM) for 48 and 72 h of treatment, respectively compared to Curcumin with IC 50 of 17.49 μM and 12.53 μM for 48 and 72 h of treatment, respectively. Results from in vitro expression studies with qPCR confirmed an antagonistic effect of dichapetalin M on PXR (NR1I2) signaling; supporting the PXR signaling pathway as a possible mode of action of dichapetalin M as predicted by in silico results. These findings confirm previous studies that D. madagascariense can be a source of potential lead compounds for development of novel antibiotic, antiparasitic and anticancer medicines, and provide further insights into the mechanism of action of the dichapetalins. In silico and biologiacl acivities of dichapetalins A and M from Dichapetalum madagascariense plant. Image 1 • Dichapetalins A and M from Dichapetalum madagascariense were more active than ampicillin, against Bacillus cereus. • Dichapetalin M was cytotoxic to MCF-7 cells. • Dichapetalins A and M predicted PIP5K1C, PPM1B, SHBG, NR1H4 and NR112 targets. • Dichapetalin M was antagonist to PXR receptor by down-regulating the expression of CYP3A4. • Activity of dichapetalins A and M validates the antibacterial use of D. madagascariense in traditional medicine. [ABSTRACT FROM AUTHOR]